Dr. Elad Sharon, MD

  • Boston, MA
  • Medical oncologist
NPI1467480160PAC ID0648277640
Medicare services, 2024
150
Medicare patients, 2024
74
Part D claims, 2024
24
Publications
150
Clinical trials
1
Practice address
450 Brookline Avenue, Boston, MA 02115
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Dana-Farber Cancer Institute

Hospital · Boston, Massachusetts

Find Dr. Sharon's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Elad Sharon is a medical oncologist in Boston, Massachusetts

Dr. Sharon practices at Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.

Dr. Sharon's NPI, 1467480160, was assigned on June 29, 2006. Dr. Sharon graduated from Baylor College of Medicine in 2003. Dr. Sharon holds Massachusetts license 238143.

NPI and contact details
Medicare PAC ID
0648277640
NPI enumeration date
June 29, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
49
Medical school graduation
2003

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Elad Sharon practices at Dana-Farber Cancer Institute in Boston, Massachusetts

Dr. Sharon's primary practice is Dana-Farber Cancer Institute, at 450 Brookline Avenue, Boston, MA 02115.

Source: Dmand AI Affiliation Data

Dr. Elad Sharon is affiliated with 2 sites of care and 1 medical group

Dr. Sharon's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dr. Sharon is also affiliated with Brigham and Women's Hospital. The medical group on file is Binney Medical Group.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Elad Sharon's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sharon practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dana-Farber Cancer InstituteAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Sharon practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Dana-Farber Cancer Institute and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Elad Sharon is one of 290 medical oncologists in Massachusetts

Medical oncology is Dr. Sharon's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Sharon's licenses on file in 2 states: Massachusetts and Georgia.

Specialties and state licenses

  • Medical oncology, MassachusettsPrimaryLicense 238143 · taxonomy 207RX0202X
  • Internal medicine, GeorgiaLicense 057675 · taxonomy 207R00000X

Medical oncologists near Dr. Sharon

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Elad Sharon billed Medicare for 150 services in 2024

CMS data shows 150 Medicare services from Dr. Sharon across 4 procedure codes in 2024, for 74 Medicare patients. Medicare paid $17,614 for them.

Medicare services, 2024150
Medicare patients74
Paid by Medicare$17,614
Procedure codes4

Dr. Sharon's Medicare services by type, 2016 to 2024

  • 2016
  • 2024
Office and hospital visits
2016: 252024: 150500%

Where Dr. Sharon's Medicare services took place, 2024

  • In an office3423%
  • In a facility11677%

Dr. Sharon compared with the Massachusetts median for medical oncologists, 2024

  • Dr. Sharon
  • Massachusetts median
Medicare services
150vs 26042% below
Medicare patients
74vs 10932% below

Medians across 259 medical oncologists in Massachusetts with Dmand AI profiles that report each measure.

Dr. Sharon's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Sharon

Need commercial claims for Dr. Sharon?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Sharon and other medical oncologists in Massachusetts.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Elad Sharon treated 74 Medicare patients in 2024, average age 73

CMS counts 74 Medicare patients who saw Dr. Sharon in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sharon's median patient age at 69, with 48% women.

Medicare patients, 202474
Average age73
Average risk score2.67
Also on Medicaid30%

Dr. Sharon's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Sharon's Medicare patients by sex, 2024

  • Women3851%
  • Men3649%

Chronic conditions among Dr. Sharon's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer73%
  4. Anxiety51%
  5. Chronic kidney disease47%
  6. Mood disorders47%
  7. Arthritis45%
  8. Depression43%

Share of Medicare patients with each condition. A patient can have several.

Dr. Sharon's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women48%
  • Men51%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Elad Sharon wrote 24 Medicare Part D claims in 2024

In 2024, Dr. Sharon wrote 24 Medicare Part D claims for 11 patients. 96% of them were for generic drugs.

Part D claims, 202424
Part D patients11

Dr. Sharon's Part D claims by kind of drug, 2024

  • Generic23 claims96%
  • Brand-name and other1 claims4%

Source: Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Elad Sharon scored 84 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sharon for performance year 2024, reported as part of a group. Dr. Sharon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sharon as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Sharon's MIPS scores, performance year 2024

  • 84of 100Final score
  • 65of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 69of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Sharon by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Elad Sharon has 150 publications on record

Dmand AI links 150 papers to Dr. Sharon, published from 2010 to 2025. 2021 was the busiest year, with 19. The most frequent topics are Immune Checkpoint Inhibitors, Antineoplastic Combined Chemotherapy Protocols and Immunotherapy. Dr. Sharon has published most often in J Immunother Cancer. Dr. Sharon's most frequent co-authors are Sandip Pravin Patel, MD, Charles David Blanke, MD and Razelle Kurzrock, MD.

Papers150
Years published2010 to 2025

Dr. Sharon's papers by year, 2016 to 2025

Topics Dr. Sharon writes about most

  • Immune Checkpoint Inhibitors
  • Antineoplastic Combined Chemotherapy Protocols
  • Immunotherapy
  • Ipilimumab
  • Nivolumab
  • Programmed Cell Death 1 Receptor
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological

Dr. Sharon's most frequent co-authors

Recent publications by Dr. Sharon

See all 150 publications and co-authors

See who Dr. Sharon researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sharon works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Elad Sharon has worked on 1 clinical trial

Dmand AI links Dr. Sharon to 1 clinical trial. Conditions studied include Hematologic Neoplasms and Multiple Myeloma.

Conditions in Dr. Sharon's trials

  • Hematologic Neoplasms
  • Multiple Myeloma

Recent clinical trials with Dr. Sharon

Hematologic NeoplasmsMultiple MyelomaMessenger ribonucleic acid (mRNA)-1273 VaccineMessenger ribonucleic acid (mRNA)-1273 Vaccine Booster

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Elad Sharon received $3,239 in industry payments from 2017 to 2025

CMS Open Payments shows 11 general payments to Dr. Sharon from 6 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 75% of the total. Mallinckrodt Hospital Products Inc. paid the most, $2,498.

General payments to Dr. Sharon by program year, 2017 to 2025

General payments to Dr. Sharon by kind, 2017 to 2025

$3.2Kin total
  • Consulting fees$2,44075%
  • Food and beverage$79925%

Companies that paid Dr. Sharon the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Sharon

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Elad Sharon graduated from Baylor College of Medicine

Dr. Sharon graduated from Baylor College of Medicine in 2003.

  1. Medical schoolBaylor College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Elad Sharon's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Elad Sharon

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Elad Sharon's NPI number?

Dr. Elad Sharon's NPI number is 1467480160. It was assigned on June 29, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Elad Sharon?

Dr. Elad Sharon is a medical oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Elad Sharon practice?

Dr. Sharon practices at 450 Brookline Avenue, Boston, MA 02115. Dr. Sharon's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.

What is Dr. Elad Sharon's medical license number?

Dr. Sharon holds Massachusetts license 238143, one of the licenses on file in 2 states.

Which states has Dr. Elad Sharon been licensed in?

Dmand AI has state licenses on file for Dr. Sharon in Massachusetts and Georgia.

Which hospitals is Dr. Elad Sharon affiliated with?

Dr. Sharon practices at Dana-Farber Cancer Institute in Boston, Massachusetts. Dr. Sharon is also affiliated with Brigham and Women's Hospital.

What medical group is Dr. Elad Sharon part of?

Dr. Sharon is linked to Binney Medical Group.

Does Dr. Elad Sharon accept Medicare?

Yes. CMS data shows Dr. Sharon billed Medicare for 150 services in 2024, and Dr. Sharon accepts Medicare assignment.

Does Dr. Elad Sharon offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Sharon as offering telehealth services.

What is Dr. Elad Sharon's MIPS score?

Dr. Sharon's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.

Show 7 more questionsShow fewer questions

How many Medicare patients does Dr. Elad Sharon see?

CMS counts 74 Medicare patients who saw Dr. Sharon in 2024, with an average age of 73.

What services does Dr. Elad Sharon bill to Medicare?

In 2024, Dr. Sharon's most billed Medicare services were hospital inpatient care (99233), office visit, established patient (99215) and office visit, new patient (99205).

Where did Dr. Elad Sharon go to medical school?

Dr. Sharon graduated from Baylor College of Medicine in 2003.

Has Dr. Elad Sharon received payments from drug or device companies?

CMS Open Payments shows $3,239 in general payments to Dr. Sharon from 6 companies from 2017 to 2025. The largest total came from Mallinckrodt Hospital Products Inc.

How long has Dr. Elad Sharon been practicing?

Dr. Sharon graduated from medical school in 2003, 23 years ago.

Does Dr. Elad Sharon do research?

Dmand AI links 150 publications to Dr. Sharon, published from 2010 to 2025. Dr. Sharon has worked on 1 clinical trial.

Who does Dr. Elad Sharon publish with?

Dr. Sharon's most frequent co-authors are Sandip Pravin Patel, MD (13 shared papers), Charles David Blanke, MD (12 shared papers) and Razelle Kurzrock, MD (12 shared papers).

Selling to medical oncology practices?

See medical oncologists in Massachusetts by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)